TIMP1 and Hepatic fibrosis: OATD-01 and ALK5i demonstrated efficacy in parameters such as serum biomarkers – AspAT (Figure 3C), as well as biomarkers from ELF panel (enhanced liver fibrosis – measured serum levels of procollagen 1, TIMP-1 and hyaluronian) (Figures 3D–F).